A randomised, double blind, placebo controlled, parallel group, 14 day repeat dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of inhaled GW685698X containing magnesium stearate in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Asthma; Perennial allergic rhinitis; Seasonal allergic rhinitis
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 15 Oct 2008 Actual initiation date changed from 1 Mar 2007 to 1 Feb 2007 as reported by ClinicalTrials.gov.
- 24 Mar 2008 New trial record.